Anne Klibanski, M.D., is the President and Chief Executive Officer of Mass General Brigham, a Boston-based integrated healthcare system that includes internationally known Brigham and Women’s Hospital and Massachusetts General Hospital, nationally recognized specialty hospitals, including Mass Eye and Ear, McLean, and Spaulding Rehabilitation, seven community hospitals, a health insurance company, physician networks, community health centers, home- based care, and long-term care services. Appointed to her role as President and CEO in 2019, Dr. Klibanski’s vision for Mass General Brigham is to build the integrated academic health care system of the future with patients at the center, by transforming care, improving outcomes, and expanding impact locally, nationally, and globally. As the largest private employer in Massachusetts with 82,000 employees and annual revenue of $16 billion, the non-profit healthcare system is the nation’s leading recipient of National Institutes of Health funding and is a principal teaching affiliate of Harvard Medical School, establishing its position as a national leader in medical research and teaching. Dr. Klibanski has led clinical integration of services across Mass General Brigham and is responsible for the development of new digital platforms to achieve digital care, including virtual urgent care, to make it easier for patients to access the system’s world-class care. She has overseen increased investment in leading-edge research that has the potential to revolutionize treatments, such as gene and cell therapy, leveraging the system’s $2.3 billion in annual research funding. The system’s innovation team has created more than 300 companies that are making broad impacts on human health, in various spaces - from therapeutics to diagnostics and research. Under Dr. Klibanski’s leadership, Mass General Brigham has also committed significant resources to community health, with a particular investment in mental health programs. She has established “United Against Racism,” a long-term multi-year commitment to address the impacts that racism has on Mass General Brigham patients, employees, and the broader community. Dr. Klibanski served as the healthcare system’s Chief Academic Officer from 2012 to 2019 and as Chief of Neuroendocrine at Massachusetts General Hospital. She is recognized internationally for her high-impact research in neuroendocrine disorders and pituitary tumors. Dr. Klibanski received her B.A., magna cum laude in literature from Barnard College and her M.D. from New York University Medical Center. She is the Laurie Carrol Guthart Professor of Medicine at Harvard Medical School.